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(LIFR)* interacts with gp130 to induce an intra-
cellular signal cascade. The LIFR-gp130 heterodimer is
implicated in the function of diverse systems. Normal 
placentation is disrupted in LIFR mutant animals, which
leads to poor intrauterine nutrition but allows fetuses 
to continue to term. Fetal bone volume is reduced greater
than three-fold and the number of osteoclasts is 
increased six-fold, resulting in severe osteopenia of
perinatal bone. Astrocyte numbers are reduced in the
spinal cord and brain stem. Late gestation fetal livers
contain relatively high stores of glycogen, indicating a
metabolic disorder. Hematologic and primordial germ 
cell compartments appear normal. Pleiotropic defects in
the mutant animals preclude survival beyond the day of
birth. 
*Also referred to as LIF receptor β (LIFRβ; Ip, N. Y. and
Yancopoulos, G. D. (1992) Prog. Growth Factor Res. 4, 139-
155).
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SUMMARYINTRODUCTION
Heterodimerization of low-affinity LIFR with gp130 is
required for the biological activities of LIF and ciliary neu-
rotrophic factor (CNTF) (for reviews see Gearing, 1993;
Kishimoto et al., 1994). Absence of membrane-bound LIFR in
mice would eliminate binding of LIF with either low or high
affinity (Gearing et al., 1991, 1992; Davis et al., 1993) and
eliminate signaling induced by ligand-bound CNTFRα (Ip et
al., 1992; Gearing et al., 1994). Soluble LIFR serves as an
antagonist to LIF signal induction (Layton et al., 1992);
therefore, absence of soluble LIFR removes a naturally
occurring antagonist. Additionally, human oncostatin M
(OSM) can bind murine gp130 and induce a signal through
murine LIFR (Gearing and Bruce, 1992; Gearing et al., 1992),
although murine OSM has not yet been reported. 
LIF has been implicated in murine development beginningfrom early embryogenesis (Conquet and Brulet, 1990; Murray
et al., 1990). Some of the paradoxical data concerning the
effects of LIF can be explained by the differences in develop-
mental stage of the cells at the site of activity. LIF suppresses
differentiation in embryonic stem (ES) cells (Smith et al.,
1988; Williams et al., 1988) and is a survival and proliferation
factor for primordial germ cells (PGC) (De Felici and Dolci,
1991; Godin et al., 1991; Matsui et al., 1991; Resnick et al.,
1992). Hematopoietic effects of LIF include enhanced
megakaryocyte production (Metcalf et al., 1990), platelet pro-
duction after thrombocytopenia (Metcalf et al., 1992) and
augmented proliferation of hematopoietic stem cells in con-
junction with IL-3 (Leary et al., 1990; Verfaillie and McGlave,
1991). LIF induces differentiation of M1 myeloid leukemia
cells (Tomida et al., 1984) into macrophage-like cells (Metcalf
et al., 1988). Enhanced retroviral infection rate of progenitor-
enriched bone marrow cultured with LIF (Fletcher et al., 1990,
1284 C. B. Ware and others1991) implicates LIF in hematopoietic progenitor cell survival.
Osteoblasts, which both produce LIF and display LIFR, affect
bone homeostasis (Allan et al., 1990), whereas LIF has been
shown to regulate bone resorption indirectly via osteoclasts
(Martin et al., 1992). Metabolic effects of LIF are suggested
by LIF-induced inhibition of lipoprotein lipase production by
melanoma cells (Mori et al., 1989) and by cachexia resulting
from the chronic overproduction of LIF following introduction
of LIF transgenes (Metcalf and Gearing, 1989a; Metcalf et al.,
1990). Thus, the range of responses to LIF among individual
cell types is broad and varies throughout development. 
LIF also functions as a neurotrophic molecule. LIF is
involved in development of fetal sensory neurons from the
murine neural crest and dorsal root ganglia (DRG) (Murphy et
al., 1991, 1993). After differentiation, LIF acts as a survival
factor in fetal sensory neurons (Murphy et al., 1991; Hendry
et al., 1992; Thaler et al., 1994) and fetal motoneurons
(Martinou et al., 1992). It also supports the survival of
postnatal sympathetic neurons but not until postnatal day 6
(Kotzbauer et al., 1994). Prior to this LIF has been found to
trigger cell death (Kessler et al., 1993). Retrograde transport
of LIF by sympathetic (Ure and Campenot, 1994) motor and
sensory neurons (Hendry et al., 1992; Curtis et al., 1994) after
injury suggests a role in peripheral nerve regeneration. LIF
serves as a cholinergic nerve differentiation factor (Fukada,
1985; Yamamori et al., 1989; Bamber et al., 1994). This neu-
rotransmitter switch can be compensated for by other factors
in the fetus but is required during adult sympathetic neuron
repair for switching to occur (Rao et al., 1993). LIF promotes
the growth, maturation and survival of oligodendrocytes in
vitro (Mayer et al., 1994). Pleiotropic LIF effects detected to
date in the nervous system encompass mitogenicity, differen-
tiation, cell survival and cell death, similar to the spectrum of
effects of LIF seen in other physiological systems. 
The gene for LIF has been disrupted by targeted mutation
(Stewart et al., 1992; Escary et al., 1993). Mice homozygous
for the mutation (LIF−/−) display retarded postnatal growth.
Regardless of genotype, blastocysts from LIF−/− females are
viable but unable to implant unless transplanted into a LIF+/+
or +/− pseudopregnant recipient, implicating a requirement for
uterine endometrial LIF in the implantation process (Stewart
et al., 1992). Absence of LIF reduces the number of myeloid
progenitors in the spleen and impairs thymic T cell activation.
However, transplantation of LIF−/− spleen or marrow cells
into a wild-type host can sustain long-term host survival. This
indicates the pluripotentiality of LIF−/− stem cells and the
importance of LIF in the microenvironment (Escary et al.,
1993).
The effects of CNTF are most apparent in the central and
peripheral nervous systems. Activities attributable to CNTF are
also attributable to LIF because of the shared requirement for
the utilization of LIFR in combination with gp130 to promote
cellular responses (for a review see Ip et al., 1992). Outside the
nervous system, CNTF, like LIF, maintains ES cells in an
undifferentiated state (Wolf et al., 1994; Yoshida et al., 1994),
contributes to PGC survival (Cheng et al., 1994) and is impli-
cated in the acute phase response (Akira et al., 1994; Lütticken
et al., 1994). Disruption of the gene that encodes CNTF leads
to an increase in atrophy of spinal motoneurons in homozy-
gous mutant mice aged 8 weeks or older. Atrophy results in a
slight reduction in muscle strength (Masu et al., 1993). Theabsence of the LIFR gene would be expected to cause neural
defects at least as severe as those seen in adult CNTF−/− mice.
Interestingly, a CNTF null mutation in humans appears to
cause no neurological defects (Takahashi et al., 1994).
In this study, we show that targeted mutation of LIFR causes
perinatal death. Homozygous mutant pups die during or shortly
after birth if they are delivered vaginally and during the first
day (P1) if delivered by Cesarean section. There are fewer
LIFR−/− fetuses than expected. Placental architecture is
disrupted in the LIFR−/− fetuses with a commensurate rescue
response by the maternal vasculature. LIFR−/− fetuses appear
grossly normal, but histological sections of late-term fetuses
indicate they suffer from profound mineralized bone loss,
increased liver glycogen levels and a reduction in numbers of
spinal cord and brainstem astrocytes. Contrary to expectation,
neither the hematopoietic system nor the primordial germ cell
compartment is obviously affected. The cause of perinatal
lethality is suspected to be a combination of events due to the
pleiotropic nature of the defects.
MATERIALS AND METHODS
Construction of targeting vector 
A murine 129/Sv genomic library (Stratagene) was screened with a
radiolabeled murine LIFR cDNA probe (Gearing et al., 1991). One
clone, which contained the initiator methionine, was isolated and
characterized by Southern blot analysis and DNA sequencing. A 7.5
kb XbaI-SalI fragment, from which a 120 bp fragment encompassing
the start codon (ATG) had been deleted, was subcloned into a
pGEM11 vector (Promega). A promoterless lacZ reporter gene
(similar to that described by Soriano et al., 1991; Renshaw and
Peschon, unpublished data) was fused to the neomycin (neo) resis-
tance gene to produce a cassette encoding the lacZ/neo resistance
fusion protein. This cassette was inserted just 3′ of the absent LIFR
ATG. This vector contained 1.8 kb of LIFR homology 5′ and 5.6 kb
of homology 3′ of the cassette. The lacZ/neo fusion cassette was
driven by the LIFR promoter, which was left intact. NotI was used to
linearize the vector prior to electroporation. 
Electroporation and selection of ES cells
AB1 embryonic stem (ES) cells were grown on irradiated SNL feeder
layers (Soriano et al., 1991) in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 15% fetal bovine serum (FBS, Schenk
Packing, 0.22µm filtered, 3000 R γ-irradiated) and 10−4 M β-mercap-
toethanol (ES medium) at 37°C in 5% CO2 in air. ES cells (2× 107
per electroporation) were electroporated with a single pulse at 200
V/960 µF using a Gene Pulser (Bio-Rad) electroporator. Cells were
plated on SNL feeder layers. ES medium containing G418 (175 µg/ml
effective concentration; Gibco) was added 24 hours after electropo-
ration. Cells were cultured under selection until well-formed colonies
were observed (12-14 days). Individual colonies were plated into one
well of a 24-well plate seeded previously with SNL feeder cells. 
Analysis of targeted clones
DNA extracted from cultured cells was subjected to PCR amplifica-
tion. The primers used were 5′-TTCCCAGTCACGACGTTG-3′
(antisense 5′ lacZ primer; P2) and 5′-CCAGAACTTGTTCAC-
TCATC-3′ (LIFR sense primer; P1) to complement sequences 5′ of
the lacZ/neo insertion and sequences within the lacZ cassette (Fig.
1a,b). Only targeted clones would generate an amplification product
of 1.8 kb.
Targeted clones were verified by Southern blot analysis. Genomic
DNA from each targeted clone and from wild-type AB1 cells was
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fragment immediately upstream of the 5′ terminus of the targeting
vector. This probe hybridized with a 12.0 kb fragment in wild-type
DNA. The targeting vector supplied a new EcoRI site downstream of
the 5′ EcoRI site and, therefore, the probe hybridized with a 2.9 kb
fragment in the targeted DNA (Fig. 1b-d).
Generation of chimeric mice 
Approximately 15 ES cells with one correctly targeted LIFR allele
were injected into the blastocoel of each E3.5 C57BL/6 blastocyst and
transferred to uteri of E2.5 pseudopregnant Swiss Webster recipients,
as described (Bradley, 1987). Transmission of the mutant allele was
detected by PCR analysis after mating to 129/J females.
Genotype analysis
Heterozygosity (+/−) for LIFR was determined by the presence of the
neo portion of the lacZ/neo insertion cassette. PCR amplification
combined four primers: 5′-GCCCTGAATGAACTGCAGGACG-3′
(neo sense strand, P5) and 5′-CACGGGTAGCCAACGCTATGTC-3′
(neo antisense strand, P6) which amplified a 500 bp product (Fig. 1c)
and primers to detect β2-microglobulin (data not shown).
DNA to determine all allelic states resulting from matings of
LIFR+/− × +/− animals was prepared for genotyping by PCR analysis.
The PCR reaction employed four primers: the primers described
above to amplify a 500 bp product in the neo portion of the lacZ/neo
cassette specific to the mutant allele and 5′-GGCCATCT-
GAACAGCATCTGT-3′ (LIFR sense strand, P3) and 5′-
GAAACAGGACTACTCTACGGTC-3′ (LIFR antisense strand, P4),
flank the lacZ/neo insertion and amplified a 250 bp product to detect
the wild-type allele (Fig. 1a,c,e). In some cases, PCR data were
confirmed by Southern blot analysis as described above (Fig. 1d). 
Cesarean section and fostering
Swiss Webster females as foster mothers were bred with C57BL/6
males to deliver litters on the day of Cesarean section. Pups were
derived on E18.5-19.5 by Cesarean section as described (Hogan et al.,
1986) and transferred to foster mothers.
MAP kinase activity
Pregnancies were disrupted on E12.5 and 15.5. Fetuses were dissoci-
ated by mincing followed by digestion with 1 mg/ml collagenase plus
1 mg/ml protease in PBS for 20-30 minutes and passaged through a
25-gauge needle. The cells from each fetus were plated into duplicate
wells on 6-well plates (Costar, Cambridge, MA) at 106 cells per well
and cultured to confluence in medium described for ES culture. Cells
were pretreated for 3.5 hours at 37°C in DMEM containing 1% bovine
serum albumin without FBS. Cells were stimulated with 100 ng/ml
LIF, OSM or phorbol myristate acetate (PMA) for 12 minutes. Mono-
layers were extracted after stimulation as described (Bird et al., 1991).
Cell extracts were disrupted by repeated passage through a 25-gauge
needle and cleared of cellular debris by centrifugation at 10,000 g for
30 minutes. 
Measurement of MAP kinase activity was performed as described
(Bird et al., 1991). Briefly, 10 µl of each cell extract was added to 20
µl of kinase reaction mixture containing 20 mM Hepes, pH 7.4, 10
mM magnesium chloride, 33 µM [γ-32P]ATP (2 µCi/nmol) and 1 mM
substrate peptide (RRRELVEPLTPSGE) or water, for determination
of peptide or nonspecific phosphorylation, respectively. Reactions
were stopped after 25 minutes at 30°C by addition of formic acid.
Insoluble material was removed by centrifugation for 10 minutes at
10,000 g and 30 µl of reaction mixture was spotted onto P81 phos-
phocellulose filters and Cerencov counted.
Delay of parturition
Progesterone (DepoProvera, Sigma M-1629) was dissolved in chlo-
roform to 50 mg/ml and diluted in peanut oil to 2 mg/ml. Mice wereinjected subcutaneously with 0.1 ml of peanut oil/progesterone
solution on gestational day 18.5.
Sensory neuron culture
DRG sensory neurons were isolated as described (Murphy et al.,
1993). Briefly, DRG from E19.5 and P1 (E20.5) animals were
dissected free of surrounding spinal tissue and chopped using 27-
gauge needles. They were then incubated in Hepes-buffered Eagles
medium (HEM), 0.025% trypsin, 0.001% DNase at 37°C for 30
minutes. FBS (Commonwealth Serum Laboratories, Melbourne,
Australia) was added to 20% and the cells were centrifuged for 5
minutes at 300 g. After resuspension in HEM containing 0.01%
DNase, the cells were dispersed into single-cell suspensions by
passage through 20- to 25-gauge needles. The cells were washed in
HEM containing 0.01% DNase and resuspended in Monomed
medium (Commonwealth Serum Laboratories) containing 10% FBS. 
Wells of 24-well plates that had previously been coated with 50
µg/ml fibronectin (Boehringer-Mannheim, Indianapolis, IN) for 1
hour were seeded with 200 cells per well in Monomed medium con-
taining 10% FBS and specified growth factors as follows: 103 units/ml
murine LIF (Amrad, Kew, Victoria, Australia), 50 ng/ml murine 2.5S
nerve growth factor (NGF) (Boehringer-Mannheim), 10 ng/ml rat
CNTF (Peprotech, Rocky Hill, NJ), 10 ng/ml human OSM and 10
ng/ml murine IL-6. Five replicate wells were seeded for each animal
under each culture condition. All the cells had settled in the wells after
2 hours when cultures were examined for the presence of large, phase-
bright, spherical cells which were counted as neurons. Some cultures
were independently stained for the presence of neurofilament to
confirm neuronal identity. After determination of initial neuron
numbers, the cultures were allowed to incubate at 37°C for 48 hours
when the cells were fixed and stained for neurofilament. The per-
centage survival, where 100% is the number of neurons after 2 hours,
was determined for each well. DRG from five E19.5 (2 +/+, 2 +/− and
1 −/−) and five E.20.5 (2 +/+, 2 +/− and 1 −/−) animals were assessed.
Hematopoiesis assays
Fetal liver stromal effects
Fetal liver stromas derived from LIFR+/+ and −/− E18.5 fetuses were
grown to confluency under Whitlock-Witte culture conditions
(Whitlock and Witte, 1982). Briefly, fetal livers were disrupted into
a single cell suspension and grown in RPMI 1040 plus 5% charcoal
filtered FBS (Hyclone, Logan, UT). Cultures were initiated in 6-well
plates and incubated at 37°C. Non-adherent cells were continuously
removed. After 2 weeks in culture, the confluent stroma layers were
irradiated with 2000 rads. Freshly isolated AA4.1+ LIFR+/+ or
unfractionated LIFR−/− E.17.5 fetal liver cells were seeded onto the
stroma at 1×105 nucleated cells/ml. Enrichment of AA4.1+ cells,
known to be enriched for fetal liver hematopoietic progenitors, was
performed by cell panning as described (Lyman et al., 1993). Cells
were cultured in the media described above supplemented with
murine interleukin 7 (IL-7) (10 ng/ml) and murine Steel factor (SLF)
(1 µg/ml). The resulting non-adherent cells were stained with fluo-
rescein-conjugated RA3-6B2 (to identify B220+ cells), GR-1 and
Mac-1 antibodies. Samples were analyzed on a FACScan.
Spleen colony formation on day 14
Livers were removed from E13.5 fetuses and single-cell suspensions
prepared (1 +/+, 1 +/−, 5 −/−). Individual liver suspensions were
cultured overnight in DMEM supplemented with 10% FBS (Intergen,
Purchase, NY), penicillin/streptomycin/ glutamine, non-essential amino
acids, 10 ng/ml human IL-3 and 100 ng/ml murine SLF. Hematopoi-
etic progenitor cell growth frequency was determined by the spleen
colony forming assay (CFU-s14) (Till and McCulloch, 1961). Briefly,
6- to 9-week-old adult C57BL/6 × 129 hybrid mice were exposed to
1000 rad of gamma irradiation from a 137Cs source (Mark 1 irradiator;
Shepard and Associates, Glendale, CA) at a dose rate of 245 rads per
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tion of the murine LIFR gene. (a) Schematic diagram of the wild-type
 is indicated by ATG. The box labeled ‘probe’ represents the location
etect restriction fragment length of genomic DNA on Southern blot
eting vector pMLIFR/ZN#1. (c) Diagram of the targeted mutant LIFR
ot analysis of the wild-type and mutant LIFR alleles. Positions of
indicated (2.9 kb for the mutant allele and approximately 12 kb for the
enotype analysis of ear biopsy DNA. Positions of the oligos used for
re indicated in panels a, b and c. minute. Each mouse was injected intravenously with 7×104 fetal liver
cells (6-10 mice per fetal liver). The recipient mice were killed after 14
days, the spleens were removed into Teleyesniczki’s solution and
macroscopic spleen colonies (CFU-s14) were counted.
Erythroid burst forming units
After overnight culture as described above for CFU-s14, fetal liver
cells were plated in 0.5 ml methylcellulose (Stem Cell Technologies,
Vancouver, BC) supplemented with 10 ng/ml IL-3 and 2 units/ml ery-
thropoietin at 4×104 cells/ml. Erythroid colonies (BFU-e) were
counted on day 7 of culture.
Erythroid colony morphology
Cells from individual E15.5 fetal livers (2 +/+, 2 +/−, 7 −/−) were
plated in quadruplicate at 105 cells per 35 mm plate in Iscove’s
Modified Dulbecco’s Medium (IMDM) containing 1.2% methylcel-
lulose (Fisher), 30% FBS (Summit Biotech-
nology, Fort Collins, CO), 1% BSA, 10−4 M
β-mercaptoethanol, 5 units/ml erythropoietin,
10% of 5-fold concentrated WEHI 3 condi-
tioned medium, 5% pokeweed mitogen
spleen cell conditioned medium and 50 ng/ml
recombinant rat SCF. After 8 days in culture
at 37°C colony formation was assessed with
the aid of a dissecting microscope. Colony
size was the primary criterion for distin-
guishing colony morphology. CFU-e were the
smallest colonies made up entirely of red
cells. Mature BFU-e were medium sized
colonies, also made up exclusively of hemo-
globin-bearing erythrocytes. Primitive BFU-e
were the largest colonies and comprised a
mixture of red with colorless cells. 
Histological examination
E10.5-18.5 fetuses and/or maternal-fetal
interfaces (placental attachment to decidua
and metrial gland) were fixed in 10% neutral
buffered formalin or 4% paraformaldehyde
for paraffin sectioning. Fetal paraffin blocks
were cut in 4 or 7 µm sections and deparaf-
finized and hydrated to water prior to staining.
Some fetal sections were stained with hema-
toxylin and eosin or periodic acid-Schiff
(PAS). For PAS, slides were placed in 0.5%
periodic acid (Sigma) for 10 minutes. They
were rinsed in water and placed in Schiff
reagent (Sigma) for 30 minutes, washed and
counterstained with Gill 3 hematoxylin
(Sigma). Slides treated with diastase to digest
sugars were compared with untreated slides to
control for specificity of PAS staining. 
Paraffin embedded fetal sections described
above were visualized immunohistochemi-
cally with antibodies to glial fibrillary acidic
protein (GFAP) using a Ventana ES
Immunostaining system (Ventana, Tucson,
AZ). A polyclonal rabbit GFAP antibody
(BioGenex, San Ramon, CA) was used.
Following exposure to biotinylated goat anti-
rabbit IgG (Vector, Burlingame, CA) slides
were visualized using a DAB detection kit
(Ventana, 250.001). Controls were either not
exposed to the anti-GFAP antibody or were
incubated with anti-human IgG1 prior to visu-
alization using biotinylated secondary
antibody as described above. 
Fig. 1. Targeted muta
allele. The start codon
of the probe used to d
analysis. (b) Gene targ
allele. (d) Southern bl
hybridizing bands are 
wild-type allele). (e) G
PCR analyses (P1-6) aSensory neuron cultures from DRG were fixed in methanol at −
20°C for 30 minutes, washed in PBS three times, incubated succes-
sively in HEM containing 2% FBS for one hour and exposed to an
antibody for p150 neurofilament (Chemicon, Temecula, CA) diluted
in HEM plus 1% FBS (Murphy et al., 1991). The cultures were
washed three times in PBS and incubated for 45 minutes in a biotiny-
lated anti-rabbit IgG (Vector, Burlingame, CA) diluted 1:200 in HEM
containing 2% FBS. They were washed three times in PBS and
incubated for 45 minutes with an avidin-biotin-peroxidase complex
(Vector) followed by a 6- to 10-minute incubation in diaminobenzi-
dine tetrahydrochloride (1 mg/ml) and hydrogen peroxidase (0.3% of
a 30% solution). The cultures were then washed three times in PBS
and stored as monolayers in PBS containing 0.1% sodium azide until
assessed by microscopic examination.
Lower bodies of fetuses to be used for primordial germ cell PGC
analysis were fixed in 4% paraformaldehyde for 2 hours (E10.5-11.5)
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Table1. Genotype of offspring derived from LIFR +/− ×
+/− matings
LIFR genotype
+/+ (%) +/− (%) −/− (%)
Pups at 4 weeks 225 (36) 393 (64) 0
Dead at birth 9 (35) 3 (11) 14 (54)
Fetal day: Resorbed (%)
3.5 39 (35) 53 (48) 19 (17)
9.5-11.5 74 (30) 135 (55) 36 (15) 61/306 (20)
12.5-15.5 134 (35) 183 (48) 62 (17) 61/378 (16)
17.5-19.5 187 (31) 332 (54) 90 (15) 95/572 (17)
Fetal total 434 (32.3) 703 (52.3) 207 (15.4) 217/1256 (17)
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Fig. 2. Analysis of loss of gene function following targeted
disruption of LIFR. (a) Combined data of LIF and OSM activation of
MAP kinases in cultured cells derived from whole fetuses. Values
are given as agonist induced (stimulated minus unstimulated) MAP
kinase activity as measured by cpm of phosphate (32P) incorporation
in substrate peptide. Seven animals of each genotype were compared.
Mean ± s.d. are shown for all three genotypes. The change in
phosphate incorporation from baseline as a measure of MAP kinase
activity for LIFR−/− cultures is significantly different when
compared to combined data for LIFR+/+ and +/− MAP kinase
activity (P<0.001, paired-sample t-test). (b) Response of
differentiated DRG neurons from LIFR +/+, +/− and −/− perinatal
mice to growth factors. The percentage neuronal survival was
determined by counting the individual wells after 2 days. The graph
includes data from two separate experiments with five replicate
cultures per experimental condition, except OSM and IL-6 means
which are combined data from one experiment. The data shown are
mean ± s.d. of percent survival. Survival of LIFR−/− neurons was
significantly different when compared to combined data for LIFR+/+
and +/− neuron survival (P<0.01, paired sample t-test). or 6 hours (E13.5) washed with PBS and held in PBS at 4°C until
frozen to −196°C. Three E11.5 and four E13.5 LIFR−/− fetuses were
immunohistochemically compared with wild-type littermates,
whereas two E10.5 and six E.11.5 LIFR−/− fetuses were compared
with wild-type littermates by confocal microscopy. Whole-mount
immunocytochemistry was carried out as described (Gomperts et al.,
1994). Stained embryos were examined on a confocal laser scanning
microscope (CLSM; Zeiss, Germany). All manipulations on the
CLSM were according to the protocol described (Tsarfaty et al., 1992,
1994). Alkaline phosphatase immuno-histochemistry was carried out
on frozen sections of embryos as described (Donovan et al., 1986). 
Skeletal preparations were made on E18.5 Cesarean section derived
fetuses as described (Gendron-Maguire et al., 1993). Briefly, the
fetuses were eviscerated and fixed in 100% ethanol for four days
followed by three days in acetone. They were then rinsed with water
and transferred to staining solution which contained 1 volume of 0.1%
Alizarin red S (Sigma 5533) in 95% ethanol. After staining for 10
days, the skeletons were rinsed with water, cleared with 20% glycerol
in 1% potassium hydroxide overnight at 37°C and held at room tem-
perature until cleared, at which point they were passed through 50, 80
and 100% glycerol for storage.
Mice were killed for histomorphometric analysis of bone from
E17.5 to 19.5. The femora and tibiae were removed and stripped of
soft and connective tissue and placed in 40% ethanol at 4°C then
transferred 24 hours later to 70% ethanol. Bone samples were dehy-
drated in graded ethanols (40-100%) and cleared in toluene using a
Tissue Tek VIP tissue processor (Miles Scientific, Naperville, IL).
After dehydration and clearing, the bones were infiltrated in graded
steps with methyl methacrylate at 4°C over 10 days. The bones were
then transferred to scintillation vials containing a layer of prepoly-
merized methyl methacrylate, covered in fresh methyl methacrylate
and left at room temperature for 16-24 hours. The vials were next
placed in a radiant oven at 42°C for 2-3 days to allow for complete
polymerization. The vials were removed, the blocks trimmed and
sanded in preparation for sectioning. The blocks were cut into 4 µm
longitudinal sections using a Reicher-Jung Autocut microtome (R.
Jung, Heidelberg, Germany) with a tungsten-carbide blade. The
sections were mounted on gelatin-coated slides and incubated
overnight at 42°C. After deplastification, bones were stained with
toluidine blue, pH3.7. Histomorphometric parameters (Parfitt et al.,
1987) were analyzed by Osteomeasure software (Osteometrics,
Atlanta, GA). All measurements were taken beginning at a standard
point in the femur or tibia just below the growth plate and not
including the diaphyseal area. Measurements were done on trabec-
ular bone only and did not include cortical or endosteal bone
surfaces. 
Statistical analysis 
Significant differences for MAP kinase activity and sensory neuron
survival were determined by paired-sample t-test. Differences in thehematological assays were measured by chi-square (χ2) or paired-
sample t-test. Significant differences among groups analyzed histo-
morphometrically for bone formation and resorption were calculated
by ANOVA (Scheffe F-test).
RESULTS
Homologous recombination of one allele with LIFR
targeting vector in ES cells
LIFR is expressed in ES cells (Renshaw, unpublished obser-
vation); therefore, the targeting strategy incorporated a pro-
moterless selection vector. One genomic clone was shown to
contain the exon encoding the LIFR initiator methionine. A
fragment, in which the ATG had been deleted, was subcloned
with the intention of replacing the start codon via the lacZ/neo
fusion cassette inserted just downstream of the deleted ATG.
1288 C. B. Ware and othersThe targeting vector contained 1.9 kb of homologous
sequences 5′ of the selectable marker and 5.6 kb of 3′ homol-
ogous sequences (Fig. 1a-c). 
After electroporation, G418 resistant clones carrying a LIFR
allele disrupted by homologous recombination were identifiedFig. 3. Placentas from normal (+/+, +/−) and LIFR-deficient (−/−) embry
into a spongiotrophoblastic zone (sz) and labyrinthine zone (lz). Membra
(cap), which forms the base of the placenta and is contiguous with the co
spongy and labyrinthine regions. Arrows point to large, fluid filled space
organized into distinct regions. (d) E15.5 −/− embryo. Note the lack of or
spaces in the labyrinthine region. An arrow marks an area containing mu
and a few large maternal blood spaces are present near the chorioallantoi
edematous. Vast spaces filled with maternal blood are present, particularby PCR using primers to detect incorporation of lacZ (P1 and
P2) or to amplify the wild-type LIFR allele (P3 and P4) (Fig.
1a,b). Targeted clones were verified by Southern blot analysis
(Fig. 1d). Five of fifteen G418 resistant clones carried a
disrupted LIFR allele. os. (a) E13.5 +/+ embryo. Note that the placenta is clearly organized
nes that surround the embryo are attached at the chorioallantoic plate
rd. (b) E13.5 −/− embryo. Note the lack of distinct organization into
s in the labyrinthine region. (c) E15.5 +/− embryo. The placenta is well
ganization, edema and the presence of large fluid and blood-filled
ltiple cell nuclei. (e) E17.5 +/+ embryo. The labyrinthine zone is lacy
c plate. (f) E17.5 −/− embryo. The placenta is disorganized and
ly near the chorioallantoic plate. PAS stains; size bar indicates 500 µm.
1289LIFR mutation results in perinatal deathGeneration of LIFR-deficient mice
One clone with a disrupted allele that had a normal karyotype
by G-banding (Diagnostic Cytogenetics, Seattle, WA) was able
to contribute to the coat color in two male chimeras. Offspring
of matings between the chimeras and 129/J females wereFig. 4. Comparisons of
the spongiotrophoblast/
labyrinthine zone
junctions and
chorioallantoic plate
regions of E17.5 and
E13.5 normal and
LIFR-deficient
placentas. (a,c) E17.5
+/+ embryo; (b) and 
(d) E17.5 −/− embryo.
(b) A large arrow points
to fibrin and a small
arrow points to a group
of marginated
leukocytes in a
distended maternal
blood space (mbs).
(e,g) E13.5 +/+ embryo;
(f,h) E13.5 −/− embryo;
large arrows in point to
PAS-negative areas that
have indistinct borders
and contain multiple
cell nuclei. (f) A small
arrow points to an
accumulation of PAS
positively staining
material; (h) a small
arrow points to an
apparently intact PAS
positively staining cell
in one of these spaces.
PAS stains: sz,
spongiotrophoblast
zone; lz, labyrinthine
zone; size bar indicates
100 µm. monitored by PCR of ear biopsy tissue for transmission of the
LIFR mutation. The mutant allele was detected by amplifica-
tion of the neo resistance gene (P5 and P6; Fig. 1c). Six of 20
male offspring from one chimera inherited the LIFR mutation.
Four founder males were verified to be LIFR+/− by Southern
1290 C. B. Ware and others
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Fig. 5. Analysis of fetal liver hematopoiesis following targeted
disruption of LIFR. (a) E18.5 fetal liver stromal support of E18.5 fetal
liver hematopoiesis. The number of cells is determined by a shift in
the mean fluorescence intensity as determined by FACS. There was
no significant difference between genotypes for any of the
combinations tested (χ2). (b) E13.5 fetal liver cellularity, erythroid
potential and CFU-s14 capability. Total cellularity (total cell number
× 106) of E13.5 fetal livers was determined for each genotype. BFU-e
numbers were determined following culture in methylcellulose. CFU-
s14 colonies were determined by counting fixed spleen surface
colonies. Mean ± s.d. are shown for all three genotypes. There was no
significant difference between the genotypes for any of the parameters
tested (paired-sample t-test). (c) E15.5 erythroid morphology. The
number of colonies of each erythroid compartment from CFU-e (most
mature) to primitive BFU-e (least mature) were counted following
culture and are represented as percentage of the total erythroid colony
outgrowths. Mean ± s.d. are shown for all three genotypes. There was
no significant difference between any of the genotypes (χ2).blot analysis. Matings were arranged to carry the LIFR
mutation on both inbred and outbred backgrounds. Birth of
litters from 129 strain LIFR+/− mating pairs was rare. Thus,
founder males mated to C57BL/6 females were the source of
subsequent generations carrying the mutation. The genotypes
of animals generated from +/− × +/− matings were detected by
either PCR (P3 and P4, to amplify the unaffected LIFR allele,plus P5 and P6, to amplify the neo resistance gene in the
targeted allele) (Fig. 1).
Genotypes of pups and fetuses derived from LIFR+/− × +/−
matings are represented in Table 1. There were no LIFR−/−
mice detected in PCR analysis of blood tissue taken from 4-
week-old pups from LIFR+/− × +/− matings. Otherwise +/+
and +/− pups were represented by close to Mendelian ratios
(36% +/+ versus 64% +/−). Pups found dead within a few hours
of birth (P1) were analyzed by leg biopsy. 14 of 26 pups were
LIFR−/− as confirmed by Southern blot analysis (Fig. 1d).
Pregnancies generated from LIFR+/− × +/− matings were
disrupted on days 3.5 and 9.5 to 19.5 of gestation to determine
the percentage of LIFR−/− fetuses present (Table 1). The
number of LIFR−/− fetuses from E9.5 to 11.5 is less than
expected (15% observed versus 25% expected). The genotypes
of E3.5 embryos were also skewed (17% observed versus 25%
expected) indicating that the underrepresentation of LIFR −/−
embryos may exist prior to implantation. A subtle overrepre-
sentation of LIFR +/+ animals is also present throughout
gestation (32% observed versus 28% expected). After implan-
tation there was evidence of excessive fetal resorption (17%)
as determined by counting resorption points contained within
the uterus. Advanced resorptions could not be genotyped accu-
rately due to the predominance of maternal tissues; however,
all genotypes of LIFR are represented during early resorption
(data not shown). Non-resorbed LIFR−/− fetuses were visually
indistinguishable from their littermates. 
Because LIFR−/− fetuses were present at a late stage of
pregnancy, pups were obtained by Cesarean section on E18.5
and placed with foster mothers to determine whether stress of
vaginal delivery was associated with perinatal death. No
LIFR−/− pups survived beyond the day of Cesarean birth (P1).
9 of the 13 LIFR−/− pups that were delivered by Cesarean
section died within 1.5 hours of delivery. These pups appeared
grossly normal but lacked vigor and were often rejected by the
foster mothers, as were the rare survivors of vaginal delivery.
The other four pups were accepted by the foster mothers but
died 6-16 hours after delivery although they were indistin-
guishable from their littermates in their overall vigor during
the first few hours of life. However, their stomachs contained
only white froth, whereas most of their littermates had milk in
their stomachs. All LIFR+/+ and +/− animals that were
accepted by the foster mother thrived. Several LIFR−/−
animals appeared smaller than their wild-type or heterozygous
littermates; however, not all LIFR−/− animals were relatively
small and small LIFR+/+ and +/− animals were observed. 
Analysis of loss of LIFR function in fetal LIFR−/−
fetuses
MAP kinase activity
MAP kinases become activated in a variety of cell types in
response to LIF and OSM (Thoma et al., 1994). This activity
was exploited to establish that the introduced LIFR mutation
was, in fact, a functionally null mutation. The induction of
MAP kinase activity in response to treatment with LIF or OSM
was assessed in cells derived from E12.5 and E15.5 LIFR+/+,
+/− and −/− fetuses to determine loss of LIFR function. Cells
from dissociated embryos were cultured to confluence and
stimulated with OSM, LIF or PMA, which served as a positive
control for stimulation of MAP kinase activity in all cultures.
MAP kinase activity in unstimulated cells from all three
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Table 2. Bone histomorphometry of LIFR +/+, +/− and −/− mice
Phenotype
+/+ +/− −/− Ratio
Parameter (n=5) (n=7) (n=9) −/−:+/+ −/−:+/- +/−:+/+
Bone volume (%) 13.4±0.9 15.2±0.2 4.8±0.6a 0.4 0.3 1.1
Osteoid volume (%) 2.2±0.7 2.5±0.4 1.4±0.4 0.6 0.6 1.1
Osteoid surface (%) 3.5±1.1 4.1±0.5 2.6±0.7 0.7 0.6 1.2
Osteoid thickness (µm) 1.7±0.09 1.6±0.07 1.5±0.2 0.9 0.9 0.9
Osteoclast surface (%) 0.6±0.3 0.7±0.2 4.1±0.6a 6.9 5.9 1.2
Number of osteoclasts/mm2 0.3±0.2 0.4±0.1 1.8±0.2a 6.1 4.6 1.3
Data are presented as means of numbers in each group ± standard errors. 
aIndicates significance at P<0.001 as determined by ANOVA. Significant differences (ratio) were only observed between homozygous mutant mice (−/−) and
either wild-type (+/+) or heterozygous mice (+/−).genotypes was comparable (average: 2360±786 cts/minute),
and the change of MAP kinase activity from this baseline
activity upon stimulation with the agonists is shown in Fig. 2a.
PMA was able to induce activation of MAP kinases in cells
from all genotypes (average induced MAP kinase activity: +/+
6935 cts/minute, +/− 7224 cts/minute and −/− 5432
cts/minute). LIF and OSM stimulated MAP kinase activation
significantly in LIFR+/+ and +/− cells (average induced MAP
kinase activity: +/+ 2003 cpm, +/− 1736 cpm), whereas in
LIFR−/− cells neither LIF nor OSM were able to appreciably
stimulate MAP kinase activation (average: 156 cts/minute). 
Sensory neuron survival
The ability of E19.5-20.5 LIFR−/− DRG derived sensory neurons
to survive after two days of in vitro culture in the presence of
cytokines that use LIFR to mediate survival was explored as addi-
tional evidence of a null mutation of LIFR. Because neurons
derived from animals older than E18.5 were preferred for this
assay, parturition was delayed with progesterone for 24 hours to
obtain E19.5 fetuses. E20.5 fetuses were recovered on the day of
natural parturition (E20.5=P1). The cells from the E19.5 fetuses
were cultured in either serum alone or serum supplemented with
NGF, LIF, CNTF, OSM or IL-6. The E20.5 (P1) DRG cells were
cultured in either serum alone or serum supplemented with NGF,
LIF or CNTF. None of the cultures survived in either IL-6 or
serum alone, whereas all survived in NGF regardless of genotype.
As expected, the +/+ and +/− sensory neurons survived in the
presence of cytokines that are known to use LIFR to mediate
signal transduction events (LIF, CNTF, or OSM), whereas
sensory neurons from the LIFR−/− littermates did not survive in
the presence of these cytokines (Fig. 2b). 
LIFR null ES cell lines
We have been unable to derive ES cell lines carrying targeted
disruptions of both LIFR alleles. Repeated attempts at deriving
LIFR null ES cell lines by either transfection of LIFR+/− lines
with a second targeting vector or by selection of LIFR+/− lines
in elevated G418 levels as described (Mortensen et al., 1992)
have failed (data not shown). These data argue that LIFR is
required for suppression of ES cell differentiation by LIF and,
taken with the above data, that the targeted LIFR alteration is
indeed a null mutation. 
LIFR−/− fetuses displayed disrupted placental
architecture
The only grossly detectable defect observed in LIFR−/− fetuseswas the presence of blood lacunae on some of the associated
placental/decidual/metrial gland units (maternal-fetal
interface); therefore, we looked at placental development.
Maternal-fetal interface units were sectioned and stained by
PAS to discern if this phenomenon was unique to LIFR−/−
fetuses. Blood pooling was seen to some extent in placentas
from all genotypes; however, the pools were dramatically
larger in the LIFR−/− placentas, which often extended from the
spongiotrophoblast, the placental tissue nearest the maternal
decidua, down to the chorioallantoic plate (Figs 3f,4b). LIFR
mutant placentas were edematous, with large fluid-filled
spaces, and lacked organization into distinct spongio- and
labyrinthine trophoblast zones (Fig. 3b,d,f). In contrast,
placentas from LIFR+/+ and +/− fetuses were clearly
organized (Fig. 3a,c,e). Mutant placentas contained unusual
pale grey, PAS-negative structures resembling multinucleated
cells with indistinct cell borders and aggregates of nuclei (Figs
3b, 4f). Some of these structures also contained intact PAS-
positive cells that were either spongiotrophoblast cells or
maternal natural killer-like cells (Fig. 4h). E17.5 placentas
contained excess fibrin in association with the blood lacunae,
and marginated leukocytes could be detected in some of these
enlarged maternal blood spaces (Fig. 4b). Multinucleated cells
and fluid-filled spaces of the E13.5 and 15.5 placentas were
uncommon by E17.5. The characteristic lacy appearance of the
normal labyrinthine placenta was lost by E17.5 due to thick-
ening of either the trophoblast or the underlying mesenchyme. 
Fetal hematopoiesis is relatively normal in LIFR−/−
mice 
Functionality of mutant fetal liver cells to support
hematopoiesis was assessed three ways: in vitro stroma culture
support of hematopoiesis, spleen colony formation assay and
erythroid outgrowth from fetal livers to compare the ability of
mutant versus wild-type fetal liver stroma to support growth of
mutant versus wild-type hematopoietic cells. Irradiated fetal
liver adherent stroma layers were reseeded with freshly
isolated E17.5 fetal liver cells. Cultures were supplemented
with IL-7 and SLF, a combination known to induce both
myeloid and B cell development under these culture con-
ditions. The number of cells after culture was elevated more
than six-fold when wild-type cells were cultured on a 
LIFR−/− stroma as compared to the other three groups (data
not shown). Outgrowths from these cultures were assayed by
flow cytometry to compare relative populations of Mac-1+ cells
(macrophage lineage), GR-1+ cells (granulocyte lineage) and
1292 C. B. Ware and othersB220+ cells (B cell lineage). There was no significant differ-
ence in the lineage phenotypes observed in the different
genotype combinations tested (Fig. 5a). 
Primitive progenitor cells derived from fetal liver were
assessed by determining the frequency of spleen colony
formation on day 14 (CFU-s14). Cells from individual liversFig. 6. Bone development abnormalities in LIFR-deficient animals. E18.5
stained fetuses. Note the reduction in bone density throughout the mutant
bones. (c-f) The proximal tibial growth plate by light microscopy of the h
(ps). (c,d) Note the marked reduction in bone spicules and complete abse
Osteoclasts (oc) can be observed at the interface between the hypertrophi
(e,f) The proximal tibial growth plate and the primary spongiosa of the w
large numbers of osteoclasts lining the bone surfaces which are absent in 
in lower right indicates 3 mm in a and b, 80 µm in c and d, and 40 µm in were cultured overnight in IL-3 and SLF, a combination of
cytokines previously shown to support the short-term survival
of cells capable of forming colonies (McKenna, unpublished
data). The total cell number per liver did not differ significantly
among the LIFR genotypes (Fig. 5b). After overnight culture,
the cells were injected intravenously into lethally irradiated wild-type (left) and mutant (right) fetuses. (a, b) Whole Alizarin red-
 animal, which is especially apparent near the growth plate in long
ypertrophic region of the growth plate (ht) and primary spongiosa
nce of trabeculae in the mutant as compared to the wild-type mice.
c zone and the primary spongiosa in mutant but not wild-type mice.
ild-type and mutant at higher magnification. In the mutant, note the
the wild-type bone. Size bar (b) indicates 1.5 mm in a and b. Size bar
e and f. 
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1294 C. B. Ware and othersC57BL/6 × 129 hybrid adult hosts. After 14 days the number
of macroscopic CFU-s14 colonies was determined. No signif-
icant difference in CFU-s14 was observed, though consider-
able variation in frequencies was apparent (Fig. 5b). Numbers
of committed erythroid progenitor cells in the fetal livers were
assessed by determining the frequency of erythroid burst
forming units (BFU-e) after culturing in methylcellulose of an
aliquot of the same fetal liver cells used to determine CFU-s14.
No significant difference in the frequency of BFU-e colonies
was seen among the three genotypes after 7 days of culture in
methylcellulose (Fig. 5b). 
Erythroid developmental morphology was evaluated
following outgrowth of fetal liver cells in methylcellulose to
ascertain the stage of hematopoietic development in light of
the severe placental disruption observed. There was no signif-
icant difference in maturity of erythroid colonies observed
among the genotypes (Fig. 5c). There was an insignificant
tendency toward a more primitive morphology in the LIFR−/−
animals, but it was below the limits of detection of this assay
and was not considered physiologically relevant. 
LIFR−/− animals have decreased bone volume and
increased osteoclast numbers
Adult mice respond to excess circulating LIF by increased
osteoblast numbers that result in mineralized bone overgrowth
(Metcalf and Gearing, 1989a,b); therefore, the absence of LIFR
could affect bone formation and resorption. Fetuses were
stained with Alizarin red S to detect mineralized bone (Fig.
6a,b). The mutant animals cleared noticeably faster and more
thoroughly than their +/+ or +/− littermates after Alizarin red
S staining. The skin was not removed from any of the animals
and may have contributed to the differential tissue clearing. As
stated above, the LIFR+/+ mice tend to be larger than their 
−/− littermates. Skull bones, vertebrae and ribs in the mutant
mice are noticeably less dense. One of the most striking
features of the LIFR−/− mice is the loss of density at the
proximal and distal ends of the long bones and metacarpi. In
order to evaluate bone remodeling, the femora or tibiae from
E17.5-19.5 fetuses were processed for histomorphometric
analysis and evaluated by light microscopy. Histomorphomet-
ric measurements were performed on a fixed region just below
the growth plate (primary spongiosa) (Baron et al., 1984).
Bones from wild-type and heterozygous mice were normal for
this stage of development and indistinguishable from each
other. The primary spongiosa contained numerous mineraliz-
ing spicules extending distally from the cartilaginous growth
plate, which also appeared normal. These spicules formed the
finger-like projections of the trabeculae and the resulting bone
architecture was well organized (Fig. 6c,e). Cortical bone was
of normal thickness and the bone marrow was unremarkable.
In contrast, the skeletons of homozygous mutant mice
exhibited profound changes. The most striking feature was the
loss of bone, assessed by histomorphometric analysis, which
was reduced by approximately two thirds as compared to
controls (Table 2). Although there appeared to be a general-
ized decrease in bone mass, the loss was most evident in the
primary spongiosa, which was distinctly osteopenic, with
reduced numbers of bone spicules and few if any well-formed
trabeculae (Fig. 6d,f). This resulted in the failure to develop
the normal architecture observed in control mice. The majority
of bone loss may be accounted for by the six-fold increase inosteoclast numbers and the seven-fold increase in osteoclast
surfaces (Table 2). Numerous osteoclasts were observed
attached to the few bone spicules found in the primary
spongiosa and at the interface between the calcified cartilage
and the primary spongiosa in mutant animals (Fig. 6f). Bone
formation may also be affected as indicated by a decrease
(~33%) in osteoid volume. Although this decrease was not sta-
tistically significant, the trend would contribute to the overall
decreased bone mass. However, once bone formation
commenced there was no difference observed between mutant
and control mice as reflected in osteoid thickness. The devel-
oping cortical bone appeared normal, although there was less
bone radiating from midshaft to the epiphysis.
LIFR−/− animals have fewer spinal and brainstem
astrocytes
The structures of the central nervous system of LIFR−/−
animals appeared normal or had slightly reduced staining
intensity as viewed in 4-7 µm sections of whole animals
stained with hematoxylin and eosin. It had been observed that
upon culture of neuroepithelium derived from E10.5 LIFR−/−
fetuses, astrocyte outgrowth was less than 1% that seen in neu-
roepithelium outgrowths of littermates (Koblar, unpublished
observation). Therefore, we stained fetal sections with an
antibody to GFAP, an astrocyte-specific stain. The astrocyte
numbers in the spinal cord and brain stem, as detected with
GFAP, were noticeably reduced in all spinal sections from
E17.5-18.5 LIFR−/− fetuses as compared to their +/+ and +/−
littermates (Fig. 7). E12.5 and 15.5 fetuses were negative for
GFAP regardless of genotype. Staining for GFAP was most
noticeable along the outer edge of the marginal layer of the
spinal cord in the wild-type littermates by E17.5 with scattered
staining toward the center of the mantle layer (Fig. 7a). This
effect was accentuated on E18.5 (Fig. 7c). Extremely rare cells
on the outer marginal layer of the spinal cord stained for GFAP
in the LIFR−/− E17.5 and 18.5 animals and, though numbers
were strikingly reduced, a few positively stained cells were
within the mantle layer (Fig. 7b,d). Interestingly, the neuronal
population appeared to be affected as viewed by the counter-
stain. The area between neuronal bodies appeared abnormal in
that the processes were thickened and tangled, whereas neuron
bodies containing cytoplasmic vacuoles and condensed,
pyknotic nuclei were scattered throughout the field (Fig. 7b,d).
The lesions involved the spinal cord and extended into the
brain stem, the same area where GFAP staining was prominent
in the wild-type littermates and may reflect a deficit in neuronal
survival. 
Primordial germ cells are unaffected by the LIFR
mutation
We examined PGC numbers in LIFR−/− embryos ranging in
age from 10.5 to 13.5 days post coitus. PGC numbers were
examined in whole mounts by staining with a monoclonal
antibody that recognizes PGC followed by analysis with
confocal laser scanning microscopy or by alkaline phosphatase
immuno-histochemistry on frozen sections. No differences
could be detected in the PGC populations among genotypes
either in number or gross morphology (data not shown). 
Elevated glycogen in the E18.5 LIFR−/− fetal liver 
LIF has been reported to be involved in metabolism (Metcalf
1295LIFR mutation results in perinatal deathand Gearing, 1989a; Mori et al., 1989). While histologically
examining placentas, we noticed that PAS staining of
sectioned, whole fetuses highlighted an increase in stored
glycogen in the E18.5 LIFR−/− fetal liver relative to wild-type
littermates (Fig. 8). The difference was subtle on E17.5 and
was not detectable on E15.5 or earlier. After Cesarean section,
the glycogen stores of all genotypes were rapidly metabolized
and could no longer be detected, thus ruling out a glycogen
storage disease and suggesting elevated fetal circulating sugar
levels (data not shown). Because the mutant mice die during a
period of metabolic switch from maternal to self-support, study
of metabolic defects in LIFR−/− animals is complicated by
maternal and placental influences.
DISCUSSION
The LIF−/− mutation causes a defect in the uterine
endometrium that disallows implantation (Stewart et al., 1992).
Normal implantation of LIFR−/− embryos indicates that a
direct uterine LIF-embryonic LIFR interaction is not required
for implantation but suggests LIF and LIFR are members of a
uterine cascade of events that allows implantation. Whether
LIFR is an obligatory member of this cascade cannot be
answered definitively because LIFR−/− animals do not reach
reproductive age. 
LIFR was cloned from a human placental cDNA library
(Gearing et al., 1991), and the data presented here emphasize
the requirement for LIFR in placentation. Maternal blood
pooling in the placental labyrinth is a normal process that facil-
itates nutrient exchange to the fetus. However, the extent of
pooling seen in the LIFR mutant animals is extreme. Very few
vessels containing nucleated, fetal red cells were observed in
the LIFR−/− placentas indicating a reduction in the fetal
vascular component when compared to those of the wild-type
littermates (Hunt, unpublished observation). There is precedent
for LIF effects on the cardiovascular system (Ferrara et al.,
1992; Gillett et al., 1993; Kirby et al., 1993; Lecron et al.,
1993; Moran et al., 1994). The placentas of mice and humans
contain essentially the same basic maternal and fetal cellular
elements and perform the same functions but exhibit important
structural differences. It is therefore difficult to draw exact
parallels between the morphological alterations in murine
LIFR mutant placentas and aberrant conditions of human
pregnancy. However, large maternal chorionic blood spaces
are a feature of placentas from mothers with certain metabolic
diseases such as diabetes and may also be observed in severe
preeclampsia (W. P. Faulk, personal communication). The
accumulation of placental fibrin as gestation advances is a
normal feature of pregnancy and is thought to aid in success-
ful separation of the fetus from the mother at parturition. The
excess accumulation of fibrin in the LIFR−/− placentas may
have caused premature separation of the mutant fetuses during
the events leading to vaginal delivery, which would result in
death by hypoxia of the majority of the LIFR−/− animals prior
to birth.
Previous reports that describe the requirement for SLF, LIF
and bFGF either alone or in various combinations for in vitro
primordial germ cell development focused on cells isolated
from E8.5-11.5 genital ridges (De Felici and Dolci, 1991;
Dolci et al., 1991; Matsui et al., 1991; Resnick et al., 1992).Neutralizing antibodies to LIFR block PGC survival in culture
(Cheng et al., 1994) consistent with data to support that LIF
can inhibit apoptosis of cultured PGCs (Pesce et al., 1993).
That PGC numbers are normal in LIFR−/− mice suggests either
that the antisera used in the previous study cross react with
another molecule that is itself able to bind LIF (and other
related cytokines) or that cytokine binding to gp130 alone is
sufficient for PGC survival. Because the LIF-related cytokine
OSM can also stimulate PGC proliferation in culture, binds
directly to gp130 and is thought to have its own accessory
receptor subunit, either of these explanations is plausible. The
combination of noticeable loss of the expected number of
LIFR−/− fetuses throughout gestation, an overrepresentation of
LIFR+/+ animals, normal LIFR−/− PGC appearance and the
apparent lack of a gene dose effect suggests that LIFR-deficient
germ cells may be at a subtle disadvantage after removal of
gap junctional support provided within the parental LIFR+/−
gonads. Evaluation of late gestation LIFR−/− gonads should
help reveal the role of LIFR in germ cell development.
Bone resorption and formation is a dynamic balance
between the function of osteoclasts and osteoblasts.
Osteoblasts secrete LIF and express LIFR, whereas equivalent
functions have not been detected in osteoclasts (Allan et al.,
1990). A role for LIF in osteoblast development is suggested
by its ability to potentiate or inhibit the expression of alkaline
phosphatase and type I collagen synthesis, depending on the
cells or assay used (Lorenzo et al., 1990). Hormones known to
stimulate bone resorption may also affect the production of
cytokines, like LIF, by osteoblasts (Greenfield et al., 1993).
LIF is known to induce bone resorption in cultured mouse
calvaria via a prostaglandin-mediated mechanism (Reid et al.,
1990), whereas excess LIF can inhibit bone resorption in E17
mouse metacarpal cultures, presumably due to an inability of
the fetal osteoclasts to migrate from the periosteum into the
mineralized bone (Van Beek et al., 1993). These differences
may also be attributed to the stage of differentiation of the cells
present in the organ culture.
The bone loss associated with postmenopausal osteoporosis
is due in large part to the decrease in estrogen. Estrogen
appears to function as a regulatory agent to maintain a balance
between resorption and formation (Horowitz, 1993). Loss of
the estrogen receptor, similar to the loss of the LIFR, results
in increased bone loss (Smith et al., 1994). IL-6 has been impli-
cated in the increased development of osteoclasts through its
hematopoietic activity, particularly after the loss of estrogen
(Jilka et al., 1992). IL-6-deficient mice appear to be protected
from osteoporosis because they do not lose bone in response
to estrogen loss following ovariectomy, although they retain
elevated bone turnover rates (Poli et al., 1994). IL-6 uses two
gp130 molecules, rather than LIFR and gp130, as its receptor
signaling components, suggesting that gp130 may be important
in the disease process. However, data presented here indicate
that LIFR and possibly other receptor components may play
equally important roles and that other cytokines, some of
which have yet to be defined, may also use this receptor and
therefore be involved in the osteopenia seen in the LIFR−/−
animals. It would be interesting to explore the role of LIFR in
comparison to gp130 for effects on osteoporosis. Furthermore,
it can be predicted from the phenotype of the LIFR mutant
animals that either reduction of LIFR expression or an increase
in the release of soluble receptor localized to bone would, in
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Fig. 8. Elevated glycogen levels in the LIFR−/− liver. (a) LIFR+/+
E18.5 fetal liver. Note faint staining (fuchsia) of glycogen granules.
(b) LIFR−/− E18.5 fetal liver. Note dense staining of glycogen
granules. Livers were fixed in paraformaldehyde, sectioned to 7 µm
and stained by PAS. Size bar indicates 100 µm. adult life, affect this equilibrium via the autocrine circuit of
LIF secretion and utilization by osteoblasts. Because
osteoblasts regulate osteoclastic activity (Thomson et al.,
1986), the predicted outcome of these defects would be osteo-
porosis.
Studies in vitro have suggested multiple roles for LIF and
CNTF in development of primary sensory neurons, including
regulation of survival and differentiation of neurotransmitter
properties (Nawa and Patterson, 1990; Ip et al., 1991; Murphy
et al., 1991; Rao et al., 1992; Fan and Katz, 1993). LIF inhibits
expression of the catecholamine-synthesizing enzyme tyrosine
hydroxylase (TH) in dissociate cultures of fetal rat sensory
ganglia and may play a similar role in inhibiting cate-
cholaminergic differentiation in most sensory neurons in vivo
(Fan and Katz, 1993). However, comparison of TH-immunos-
taining in the trigeminal and nodose sensory ganglia of E13.5,
17.5 and 18.5 LIFR +/+ and −/− mice revealed no apparent dif-
ference in the number of catecholaminergic sensory neurons
(Fan and Katz, personal communication). Although LIFR is
required for the regulation of neuron survival within the spinal
cord during late gestation, signaling pathways involving LIFRare not required for inhibition of catecholaminergic differen-
tiation during sensory gangliogenesis in vivo, suggesting that
other mechanisms subserve this function in the LIFR mutant
animals and perhaps during normal development.
Roles for both LIFR and gp130 astrocyte development are
indicated by the observation that serum-free mouse embryo
cells are stimulated to make GFAP in response to LIF, CNTF,
OSM or IL-6 (Nishiyama et al., 1993). LIF is made by human
fetal astrocytes (Aloisi et al., 1994) and rat glial cells (Banner
and Patterson, 1994). Thus, murine astrocytes are likely to
express LIF and these data suggest that they require LIFR either
directly or indirectly to express GFAP. Because a biological
clock determines glial development (Abney et al., 1981), the
paucity of astrocytes found in the mutant animals may not be
due to a simple delay in development, although the develop-
mental clock is being examined for alterations in these mice.
Whether the apparent inability of spinal neurons to survive is
due directly to regulation by LIFR or is related to the reduction
in astrocyte numbers is a question for future investigations.
We expect that there may be defects in LIFR−/− mice that
have not yet been investigated such as skin formation and
vascular development. The defects observed are severe in com-
parison to individual CNTF and LIF mutations. Breeding
CNTF-deficient mice with mice lacking LIF and comparing
these progeny with CNTFRα-deficient mice and mice lacking
LIFR may reveal the presence of other ligands or receptors that
directly or indirectly require LIFR to signal. It is surprising that
there is so little redundancy in LIFR function. It is likely that
the entire family of molecules, which transduce a signal
through LIFR and/or gp130, is in the process of active
evolution. As a result, we may predict that species variation
occurs in both ligand and receptor components of this family.
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